Role of CD4 T-regulator cell and their subsets in bladder cancer

Hiba Qassem Ali^¹, Mohammad F. Albadran^², Safaa G. Mezban^²

 ^¹Medical Microbiology, Al Basra Teaching Hospital, Iraq

^²Basra Nephrology and Transplantation Center, Al Sadder Teaching Hospital, Iraq

Received: May 27, 2023/ Revised: June 17 / Accepted: June 21, 2023

(✉) Corresponding Author: hibaqasem@yahoo.com

Abstract

Tumor-infiltrating lymphocytes (TILs) are candidate as crucial biomarkers since certain cancers have high lymphocyte infiltration that obtain significant role in specific cancer types that can be contributed in tumor pathogenesis. In Bladder cancer found to be highly infiltrated with T-regulator cells, and it has been found to be associated with tumor progression and poor disease outcome as well. In this study, we assess the CD4 T- regulator cells and their subsets infiltration in tumor and autologous normal microenvironments of the urinary bladder and subsequently their significance in antitumor immunology with their clinicopathological influences of urinary bladder cancer.

Keywords: T-regulator, CD4, Subsets, Bladder, Cancer

References

Akkaya, B., Oya, Y., Akkaya, M., Al Souz, J., Holstein, A. H., Kamenyeva, O. & Shevach, E. M. (2019). Regulatory T cells mediate specific suppression by depleting peptide–MHC class II from dendritic cells. Nature immunology, 20(2), 218-231.

Arterbery, A. S., Osafo-Addo, A., Avitzur, Y., Ciarleglio, M., Deng, Y., Lobritto, S. J. & Ekong, U. D. (2016). Production of proinflammatory cytokines by monocytes in liver-transplanted recipients with de novo autoimmune hepatitis is enhanced and induces TH1-like regulatory T cells. The Journal of Immunology, 196(10), 4040-4051.

Baras, A. S., Drake, C., Liu, J. J., Gandhi, N., Kates, M., Hoque, M. O. & Bivalacqua, T. J. (2016). The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder. Oncoimmunology, 5(5), e1134412.

Chi, L. J., Lu, H. T., Li, G. L., Wang, X. M., Su, Y., Xu, W. H., & Shen, B. Z. (2010). Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma. Clinical & Experimental Immunology, 161(3), 480-489.

Dominguez-Gutierrez, P. R., Crispen, P., & Kusmartsev, S. A. (2019). Tumor-produced hyaluronan contributes to the formation tolerogenic immunosuppressive microenvironment. Cancer Research, 79(13_Supplement), 1521-1521.

Jin, P., Ren, H., Sun, W., Xin, W., Zhang, H., & Hao, J. (2014). Circulating IL-35 in pancreatic ductal adenocarcinoma patients. Human immunology, 75(1), 29-33.

Kotsakis, A., Koinis, F., Katsarou, A., Gioulbasani, M., Aggouraki, D., Kentepozidis, N. & Vetsika, E. K. (2016). Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients. Scientific Reports, 6(1), 39247.

Kuczma, M., Pawlikowska, I., Kopij, M., Podolsky, R., Rempala, G. A., & Kraj, P. (2009). TCR repertoire and Foxp3 expression define functionally distinct subsets of CD4+ regulatory T cells. The Journal of Immunology, 183(5), 3118-3129.

Lin, Y. C., Chang, L. Y., Huang, C. T., Peng, H. M., Dutta, A., Chen, T. C. & Lin, C. Y. (2009). Effector/memory but not naive regulatory T cells are responsible for the loss of concomitant tumor immunity. The Journal of Immunology, 182(10), 6095-6104.

Liu, Q., Sun, Z., & Chen, L. (2020). Memory T cells: strategies for optimizing tumor immunotherapy. Protein & cell, 11(8), 549-564.

Liu, Y. N., Zhang, H., Zhang, L., Cai, T. T., Huang, D. J., He, J. & Li, J. (2019). Sphingosine 1 phosphate receptor-1 (S1P1) promotes tumor-associated regulatory T cell expansion: leading to poor survival in bladder cancer. Cell death & disease, 10(2), 50.

Loskog, A., Ninalga, C., Paul-Wetterberg, G., de la Torre, M., Malmström, P. U., & Tötterman, T. H. (2007). Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines. The Journal of urology, 177(1), 353-358.

Miyake, M., Tatsumi, Y., Gotoh, D., Ohnishi, S., Owari, T., Iida, K. & Fujimoto, K. (2017). Regulatory T cells and tumor-associated macrophages in the tumor microenvironment in non-muscle invasive bladder cancer treated with intravesical Bacille Calmette-Guérin: a long-term follow-up study of a Japanese cohort. International journal of molecular sciences, 18(10), 2186.

Mougiakakos, D., Choudhury, A., Lladser, A., Kiessling, R., & Johansson, C. C. (2010). Regulatory T cells in cancer. Advances in cancer research, 107, 57-117.

Murai, R., Itoh, Y., Kageyama, S., Nakayama, M., Ishigaki, H., Teramoto, K. & Kawauchi, A. (2018). Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3+ T cells in the primary transurethral resection of bladder tumor specimens. PloS one, 13(9), e0204745.

Nagarsheth, N., Wicha, M. S., & Zou, W. (2017). Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nature Reviews Immunology, 17(9), 559-572.

Parodi, A., Traverso, P., Kalli, F., Conteduca, G., Tardito, S., Curto, M., & Filaci, G. (2016). Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence. Oncotarget, 7(6), 6424.

Pfannstiel, C., Strissel, P. L., Chiappinelli, K. B., Sikic, D., Wach, S., Wirtz, R. M. & Eckstein, M. (2019). The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes. Cancer immunology research, 7(6), 923-938.

Povoleri, G. A. M., Scottà, C., Nova-Lamperti, E. A., John, S., Lombardi, G., & Afzali, B. (2013). Thymic versus induced regulatory T cells–who regulates the regulators?. Frontiers in immunology, 4, 169.

Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008). Regulatory T cells and immune tolerance. cell, 133(5), 775-787.

Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D. & Iacopetta, B. (2009). Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. Journal of clinical oncology, 27(2), 186-192.

Takeuchi, Y., & Nishikawa, H. (2016). Roles of regulatory T cells in cancer immunity. International immunology, 28(8), 401-409.

Ward, S. T., Li, K. K., Hepburn, E., Weston, C. J., Curbishley, S. M., Reynolds, G. M. & Adams, D. H. (2015). The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer. British journal of cancer, 112(2), 319-328.

How to cite this article

Ali, H. O., Albadran, M. F. and Mezban, S. G. (2023). Role of CD4 T-regulator cell and their subsets in Bladder Cancer. Microbial Science Archives, Vol. 3(2), 70-75 https://doi.org/10.47587/MSA.2023.3203

Licence                  Article Metadata